Cantitate/Preț
Produs

Lung Cancer

Editat de Jack A Roth, Waun Ki Hong, Ritsuko U Komaki
en Limba Engleză Hardback – 27 mai 2014
The best and most concise single source for state-of-the-art diagnosis and treatment of lung cancer -newly revised, updated, and expanded. Lung cancer has long been the number-one cause of death from cancer every year and the third most frequently diagnosed after breast and prostate cancers. In 2010, about 15% of all cancer diagnoses and 30% of all cancer deaths were due to lung cancer. Needless to say, there is a great need for more rapid advancements in diagnosis and treatment of this devastating disease. Here is the comprehensively revised, updated, and expanded edition of the well-established, evidence-based reference book that deals with the most recent advances in lung cancer prevention, screening, diagnosis, research, and treatment for the clinician. Edited and authored by leading authorities in the field, this Fourth Edition of the highly regarded Lung Cancer is better than ever -featuring nine new chapters along with seven re-formatted ones that are nearly brand new in content and approach. It covers Smoking Prevention and Cessation; Molecular Profiling; Somatic Genome Alterations in Human Lung Cancers; Management of Multi-Focal Bronchioloalveolar Carcinoma (BAC); Primary Tracheal Tumors; Predictive Tumor Biomarkers for EGFR Inhibitors; Non-Small Cell and Small-Cell Lung Carcinoma; and more. This Fourth Edition of Lung Cancer: * Provides the very latest research in the identification of biomarkers to predict a high risk for developing lung cancer - vital for implementing screening, diagnosis, and prevention strategies * Presents the newest lung cancer staging system, as well as updated and cutting-edge surgical and radiation therapy techniques that make local tumor control more effective and less invasive while sparing normal tissues * Discusses combined modality therapy and new chemotherapeutic agents which are yielding higher response rates and improved survival when used in the adjuvant setting or concurrent with highly sophisticated radiation or proton treatment * Offers novel and emergent approaches to preventative, diagnostic, and therapeutic modalities with an emphasis on the best evidence available from the latest studies and clinical trials With almost half of the revised and updated content being brand new, Lung Cancer, Fourth Edition, is an important and vital resource for all medical professionals and students involved in the care and treatment of those struck with this catastrophic illness.
Citește tot Restrânge

Preț: 97133 lei

Preț vechi: 143889 lei
-32%

Puncte Express: 1457

Preț estimativ în valută:
17171 20473$ 14894£

Carte indisponibilă temporar

Doresc să fiu notificat când acest titlu va fi disponibil:

Specificații

ISBN-13: 9781118468746
ISBN-10: 1118468740
Pagini: 616
Dimensiuni: 194 x 254 x 32 mm
Greutate: 1.38 kg
Ediția:4th Revised edition
Editura: Wiley
Locul publicării:Hoboken, United States

Public țintă

Primary audience: Medical oncologists, thoracic surgeons, and radiation oncologists who specifically treat lung cancer (about 6000 worldwide). Generalist oncologists who may also diagnose ans treat lung cancer (another 12,000+ worldwide). Oncology fellows and residents (about 5,000 worldwide). Medical students on oncology rotation (about 5,000 worldwide). Secondary audience: Physician assistants, nurse practitioners, and allied healthcare personnel specifically involved in the care and treatment of lung cancer patients (about 20,000 worldwide).

Notă biografică

Jack A. Roth, MD, F.A.C.S., is Professor and Bud Johnson Clinical Distinguished Chair in the Department of Thoracic and Cardiovascular Surgery, Professor of Molecular and Cellular Oncology, Director of the W.M. Keck Center of Innovative Cancer Therapies, and Chief of the Section of Thoracic Molecular Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA. James D. Cox, MD, is Professor and Head of the Department of Radiation Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA. Waun Ki Hong, MD, D.M.Sc. (Hon.), is the American Cancer Society Professor and Samsung Distinguished University Chair in Cancer Medicine, as well as Professor and Head of the Division of Cancer Medicine and Professor in the Department of Thoracic/Head and Neck Medical Oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas, USA.

Descriere

Lung cancer has long been the number-one cause of death from cancer every year and the third most frequently diagnosed after breast and prostate cancers. This book provides the research in the identification of biomarkers to predict a high risk for developing lung cancer.